These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 33657875)
21. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients. Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623 [No Abstract] [Full Text] [Related]
22. Interventional cardiologists' attitudes towards pharmacogenetic testing and impact on antiplatelet prescribing decisions. Hoffecker G; Kanter GP; Xu Y; Matthai W; Kolansky DM; Giri J; Tuteja S Per Med; 2022 Jan; 19(1):41-49. PubMed ID: 34881641 [TBL] [Abstract][Full Text] [Related]
23. Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory. Haga SB; Liu Y Pharmacogenomics; 2019 Jun; 20(8):581-587. PubMed ID: 31190624 [No Abstract] [Full Text] [Related]
24. Attitudes toward pharmacogenetics in patients undergoing Lee G; Varughese LA; Conway L; Stojinski C; Ashokkumar S; Monono K; Matthai W; Kolansky DM; Giri J; Tuteja S Per Med; 2022 Mar; 19(2):93-101. PubMed ID: 34984913 [TBL] [Abstract][Full Text] [Related]
25. National survey of physicians' perspectives on pharmacogenetic testing in solid organ transplantation. Deininger KM; Tsunoda SM; Hirsch JD; Anderson H; Lee YM; McIlvennan CK; Page RL; Tran JN; Aquilante CL Clin Transplant; 2020 Oct; 34(10):e14037. PubMed ID: 32654213 [TBL] [Abstract][Full Text] [Related]
26. A qualitative approach to assess the opinion of physicians about the challenges and prospects of pharmacogenomic testing implementation in clinical practice in Greece. Koufaki MI; Patrinos GP; Vasileiou KZ Hum Genomics; 2024 Jul; 18(1):82. PubMed ID: 39030587 [TBL] [Abstract][Full Text] [Related]
27. Study design and implementation of the PRecision Medicine In MEntal health Care (PRIME Care) Trial. Oslin DW; Chapman S; Duvall SL; Gelernter J; Ingram EP; Kranzler HR; Lehmann LS; Lynch JA; Lynch KG; Pyne JM; Shih MC; Stone A; Thase ME; Wray LO Contemp Clin Trials; 2021 Feb; 101():106247. PubMed ID: 33316457 [TBL] [Abstract][Full Text] [Related]
28. Patient perspectives following pharmacogenomics results disclosure in an integrated health system. Lemke AA; Hulick PJ; Wake DT; Wang C; Sereika AW; Yu KD; Glaser NS; Dunnenberger HM Pharmacogenomics; 2018 Mar; 19(4):321-331. PubMed ID: 29469671 [TBL] [Abstract][Full Text] [Related]
29. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service. Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451 [No Abstract] [Full Text] [Related]
30. Assessing the impact of pre-test education on patient knowledge, perceptions, and expectations of pharmacogenomic testing to guide antidepressant use. Sloat NT; Yashar BM; Ellingrod VL; Ward KM J Genet Couns; 2022 Dec; 31(6):1373-1382. PubMed ID: 35900228 [TBL] [Abstract][Full Text] [Related]
32. Pediatric pharmacogenomics: challenges and opportunities: on behalf of the Sanford Children's Genomic Medicine Consortium. Gregornik D; Salyakina D; Brown M; Roiko S; Ramos K Pharmacogenomics J; 2021 Feb; 21(1):8-19. PubMed ID: 32843689 [TBL] [Abstract][Full Text] [Related]
33. Knowledge and attitudes on implementing cardiovascular pharmacogenomic testing. Russell C; Campion M; Grove ME; Matsuda K; Klein TE; Ashley E; Naik H; Wheeler MT; Scott SA Clin Transl Sci; 2024 Mar; 17(3):e13737. PubMed ID: 38421234 [TBL] [Abstract][Full Text] [Related]
34. Perplexed by PGx? Exploring the impact of pharmacogenomic results on medical management, disclosures and patient behavior. Waldman L; Shuman C; Cohn I; Kaiser A; Chitayat D; Wasim S; Hazell A Pharmacogenomics; 2019 Apr; 20(5):319-329. PubMed ID: 30983503 [TBL] [Abstract][Full Text] [Related]
35. Child and adolescent psychiatrists' use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice. Soda T; Merner AR; Small BJ; Torgerson LN; Muñoz K; Austin J; Storch EA; Pereira S; Lázaro-Muñoz G Psychiatry Res; 2023 Jul; 325():115246. PubMed ID: 37172398 [TBL] [Abstract][Full Text] [Related]
36. Pharmacogenomic information in FDA-approved drug labels: Application to pediatric patients. Green DJ; Mummaneni P; Kim IW; Oh JM; Pacanowski M; Burckart GJ Clin Pharmacol Ther; 2016 Jun; 99(6):622-32. PubMed ID: 26693845 [TBL] [Abstract][Full Text] [Related]
38. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx). Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097 [TBL] [Abstract][Full Text] [Related]
39. Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization. Bar-Peled Y; Denton JJ; Richards JL; Brown D; Worthey E; Strong TV Pharmacogenomics; 2024 Mar; 25(4):207-216. PubMed ID: 38506331 [No Abstract] [Full Text] [Related]